Algert Global LLC Boosts Stock Position in Proto Labs, Inc. $PRLB

Algert Global LLC boosted its position in Proto Labs, Inc. (NYSE:PRLB) by 480.2% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 36,695 shares of the industrial products company’s stock after acquiring an additional 30,370 shares during the quarter. Algert Global LLC’s holdings in Proto Labs were worth $2,991,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. BlackRock Inc. acquired a new position in shares of Proto Labs in the 2nd quarter valued at $317,581,000. Disciplined Growth Investors Inc. MN increased its stake in shares of Proto Labs by 1.9% in the second quarter. Disciplined Growth Investors Inc. MN now owns 2,722,011 shares of the industrial products company’s stock worth $108,989,000 after purchasing an additional 51,293 shares during the period. XXEC Inc. grew its holdings in Proto Labs by 2,060.4% in the 2nd quarter. XXEC Inc. now owns 1,261,547 shares of the industrial products company’s stock valued at $111,461,682,000 after buying an additional 1,203,154 shares during the last quarter. Rubric Capital Management LP boosted its position in shares of Proto Labs by 8.6% in the third quarter. Rubric Capital Management LP now owns 1,123,338 shares of the industrial products company’s stock valued at $56,201,000 after acquiring an additional 89,167 shares during the period. Finally, American Capital Management Inc. raised its stake in Proto Labs by 126.0% during the 4th quarter. American Capital Management Inc. now owns 631,311 shares of the industrial products company’s stock valued at $31,938,000 after purchasing an additional 352,015 shares during the last quarter. Institutional investors own 84.54% of the company’s stock.

Insiders Place Their Bets

In related news, Director Sven Wehrwein sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total value of $154,560.00. Following the transaction, the director directly owned 32,505 shares in the company, valued at approximately $2,511,986.40. This represents a 5.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.30% of the company’s stock.

Proto Labs Price Performance

Proto Labs stock opened at $79.64 on Friday. Proto Labs, Inc. has a 1 year low of $45.10 and a 1 year high of $93.00. The business has a 50 day moving average of $80.43 and a 200-day moving average of $70.97. The company has a market capitalization of $1.90 billion, a P/E ratio of 63.71 and a beta of 1.40.

Proto Labs (NYSE:PRLB) last posted its quarterly earnings data on Friday, July 31st. The industrial products company reported $0.60 earnings per share for the quarter, beating analysts’ consensus estimates of $0.53 by $0.07. The business had revenue of $149.34 million during the quarter, compared to the consensus estimate of $144.53 million. Proto Labs had a return on equity of 4.80% and a net margin of 5.44%.Proto Labs’s quarterly revenue was up 10.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.41 earnings per share. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. Equities analysts anticipate that Proto Labs, Inc. will post 1.46 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have commented on PRLB. Weiss Ratings lowered shares of Proto Labs from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, August 18th. Needham & Company LLC raised shares of Proto Labs from a “hold” rating to a “buy” rating and set a $87.00 price objective on the stock in a research note on Monday, August 3rd. Benchmark upped their target price on shares of Proto Labs from $70.00 to $91.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. Zacks Research raised Proto Labs from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 6th. Finally, Wall Street Zen lowered Proto Labs from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 18th. One analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the company’s stock. According to MarketBeat.com, Proto Labs has a consensus rating of “Buy” and a consensus target price of $89.00.

Proto Labs Company Profile

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.